Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies, including daily updates, research reports, and stock screens [1][2] Zacks Style Scores - Zacks Style Scores provide ratings for stocks based on value, growth, and momentum characteristics, helping investors identify securities likely to outperform the market in the short term [2][3] - Stocks are rated from A to F, with A indicating the highest potential for outperformance [3] Value Score - The Value Score identifies attractive stocks using financial ratios such as P/E, PEG, and Price/Sales, appealing to value investors seeking undervalued opportunities [3] Growth Score - The Growth Score focuses on a company's future prospects by analyzing projected and historical earnings, sales, and cash flow, targeting stocks with sustainable growth [4] Momentum Score - The Momentum Score assesses stocks based on price trends and earnings outlook, helping investors capitalize on upward or downward price movements [5] VGM Score - The VGM Score combines the Value, Growth, and Momentum Scores, providing a comprehensive rating to identify stocks with the best overall potential [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to simplify portfolio building, with 1 (Strong Buy) stocks achieving an average annual return of +23.81% since 1988, significantly outperforming the S&P 500 [7][8] Stock Selection Strategy - Investors are encouraged to focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for the highest probability of success [10] - Stocks with a 3 (Hold) rank should also have A or B Style Scores to maximize upside potential [10] Example Stock: T. Rowe Price (TROW) - T. Rowe Price Group, Inc. manages $1.76 trillion in assets as of September 30, 2025, and is rated 3 (Hold) with a VGM Score of A [12] - TROW has a Momentum Style Score of B, with shares increasing by 6.6% over the past four weeks, and analysts have revised earnings estimates upwards [13]

Group 1: Halozyme Therapeutics - Halozyme Therapeutics is a biopharmaceutical company focused on developing and commercializing novel treatments for oncology by targeting the tumor microenvironment [1] - The company has a Zacks Rank of 1 (Strong Buy) and its current year earnings estimate has increased by 10.5% over the last 60 days [1] - Halozyme's shares have gained 36.2% over the last three months, significantly outperforming the S&P 500's gain of 7.5%, and it possesses a Momentum Score of A [2] Group 2: T. Rowe Price - T. Rowe Price is a global investment management organization offering a wide range of mutual funds, sub-advisory services, and separate account management for various investors [3] - The company also holds a Zacks Rank of 1 and has seen a 9% increase in its current year earnings estimate over the last 60 days [3] - T. Rowe Price's shares have increased by 14.2% over the last three months, again outperforming the S&P 500's gain of 7.5%, and it has a Momentum Score of A [4] Group 3: Cars.com - Cars.com operates an online automotive platform that provides listings for new and used vehicles, along with expert and consumer reviews and research tools [4] - The company has a Zacks Rank of 1 and its current year earnings estimate has risen by 2.3% over the last 60 days [4] - Cars.com's shares have appreciated by 22.3% over the last three months, surpassing the S&P 500's gain of 7.5%, and it also has a Momentum Score of A [5]